Regarding cancer treatment, Chk2 inhibitors exert promising results, such as sensitizing tumor cells to the cytotoxic effects of chemotherapy and radiotherapy or attenuating hematological cytotoxicity induced by those therapies. The gene discussed is CHEK2; the disease is neoplasm.